• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management.

作者信息

Giustozzi Michela, Vedovati Maria Cristina, Agnelli Giancarlo

机构信息

Internal Vascular and Emergency Medicine and Stroke Unit, University of Perugia, Perugia, Italy.

出版信息

Eur J Intern Med. 2020 Dec;82:18-20. doi: 10.1016/j.ejim.2020.10.018. Epub 2020 Oct 22.

DOI:10.1016/j.ejim.2020.10.018
PMID:33127217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7580525/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/7580525/a518b208b463/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/7580525/a518b208b463/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1807/7580525/a518b208b463/gr1_lrg.jpg

相似文献

1
Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management.静脉血栓栓塞与2019冠状病毒病：关注临床流行病学与患者管理之间的差距。
Eur J Intern Med. 2020 Dec;82:18-20. doi: 10.1016/j.ejim.2020.10.018. Epub 2020 Oct 22.
2
Thromboprophylaxis for medical inpatients with coronavirus disease 2019.2019年冠状病毒病成年住院患者的血栓预防
Clin Microbiol Infect. 2020 Sep;26(9):1125-1126. doi: 10.1016/j.cmi.2020.05.021. Epub 2020 May 23.
3
Highlights in COVID-19 from the 62nd American Society of Hematology Annual Meeting.第62届美国血液学会年会中关于新型冠状病毒肺炎的亮点
Clin Adv Hematol Oncol. 2021 Mar;19(3):140-143.
4
Evidence-based medicine requires appropriate clinical context.
JAMA. 2010 Feb 3;303(5):454-5. doi: 10.1001/jama.2010.47.
5
Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study).首次发生静脉血栓栓塞症入院患者中诊断出的偶然静脉血栓栓塞症：发生率及临床意义（一项观察性研究）
Thromb Res. 2016 Aug;144:116-8. doi: 10.1016/j.thromres.2016.06.018. Epub 2016 Jun 16.
6
Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale.新冠病毒肺炎住院患者静脉血栓栓塞症经验性抗凝治疗的患病率及后果：一则警示故事
J Thromb Thrombolysis. 2021 Nov;52(4):1056-1060. doi: 10.1007/s11239-021-02471-x. Epub 2021 May 3.
7
Rate of Recurrence After Discontinuing Anticoagulation Therapy in Patients With COVID-19-Associated Venous Thromboembolism.新冠病毒相关静脉血栓栓塞症患者停用抗凝治疗后的复发率
JAMA Intern Med. 2022 Dec 1;182(12):1326-1328. doi: 10.1001/jamainternmed.2022.4954.
8
Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis.COVID-19 诊断后住院和非住院患者的血栓并发症发生率。
Br J Haematol. 2021 Aug;194(3):542-546. doi: 10.1111/bjh.17522. Epub 2021 May 24.
9
Anticoagulation in hospitalized patients with COVID-19.COVID-19 住院患者的抗凝治疗。
Blood. 2022 Aug 25;140(8):809-814. doi: 10.1182/blood.2021014527.
10
Antithrombotic Therapies in COVID-19 Disease: a Systematic Review.抗血栓治疗在 COVID-19 疾病中的应用：一项系统评价。
J Gen Intern Med. 2020 Sep;35(9):2698-2706. doi: 10.1007/s11606-020-05906-y. Epub 2020 Jun 17.

引用本文的文献

1
Biomarkers in Venous Thrombosis: Diagnostic Potential and Limitations.静脉血栓形成中的生物标志物：诊断潜力与局限性
Biology (Basel). 2025 Jul 1;14(7):800. doi: 10.3390/biology14070800.
2
The characteristics of acute macular neuroretinopathy following COVID-19 infection.急性黄斑神经视网膜病变的特点，继 COVID-19 感染之后。
BMC Ophthalmol. 2024 Jan 10;24(1):19. doi: 10.1186/s12886-024-03283-2.
3
Development of prospective hospital-based venous thromboembolism registry across India: a study protocol.印度前瞻性医院静脉血栓栓塞症登记处的建立：研究方案。

本文引用的文献

1
Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.新型冠状病毒肺炎患者急性肺栓塞的发生率：系统评价和荟萃分析。
Eur J Intern Med. 2020 Dec;82:29-37. doi: 10.1016/j.ejim.2020.09.006. Epub 2020 Sep 17.
2
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration.COVID-19 住院患者的抗凝干预措施：随机对照试验的范围综述及国际合作呼吁。
J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1.
3
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies.
BMJ Open. 2023 Aug 9;13(8):e066644. doi: 10.1136/bmjopen-2022-066644.
4
Biological mechanisms underpinning the development of long COVID.长期新冠发展背后的生物学机制。
iScience. 2023 Jun 16;26(6):106935. doi: 10.1016/j.isci.2023.106935. Epub 2023 May 18.
5
Estimating incidence of venous thromboembolism in COVID-19: Methodological considerations.估算新型冠状病毒肺炎患者静脉血栓栓塞症的发病率：方法学考量
Res Pract Thromb Haemost. 2022 Aug 15;6(6):e12776. doi: 10.1002/rth2.12776. eCollection 2022 Aug.
6
Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment.新型冠状病毒病相关凝血障碍的要点：管理和治疗的要点。
Postgrad Med. 2021 Nov;133(8):899-911. doi: 10.1080/00325481.2021.1974212. Epub 2021 Sep 11.
7
Prevalence of proximal deep vein thrombosis in hospitalized COVID-19 patients.住院COVID-19患者近端深静脉血栓形成的患病率。
Eur J Intern Med. 2021 Jul;89:118-120. doi: 10.1016/j.ejim.2021.03.034. Epub 2021 Apr 8.
COVID-19 和静脉血栓栓塞症：文献研究的荟萃分析。
Semin Thromb Hemost. 2020 Oct;46(7):763-771. doi: 10.1055/s-0040-1715456. Epub 2020 Sep 3.
4
Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis.2019年冠状病毒病住院患者静脉血栓栓塞的发生率：一项系统评价和荟萃分析
Front Cardiovasc Med. 2020 Aug 6;7:151. doi: 10.3389/fcvm.2020.00151. eCollection 2020.
5
Venous Thromboembolism in Hospitalized COVID-19 Patients: Systematic Review.住院COVID-19患者的静脉血栓栓塞：系统评价
Interact J Med Res. 2020 Sep 1;9(3):e22768. doi: 10.2196/22768.
6
Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis.接受血栓预防的COVID-19住院患者的静脉血栓栓塞：一项系统评价和荟萃分析
J Clin Med. 2020 Aug 3;9(8):2489. doi: 10.3390/jcm9082489.
7
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis.危重症 COVID-19 患者接受预防性或治疗性抗凝治疗时的静脉血栓栓塞症：系统评价和荟萃分析。
J Thromb Thrombolysis. 2020 Nov;50(4):814-821. doi: 10.1007/s11239-020-02235-z.
8
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis.COVID-19 住院非 ICU 患者尽管接受了药物预防血栓形成，但仍有深静脉血栓形成的发生率。
J Thromb Haemost. 2020 Sep;18(9):2358-2363. doi: 10.1111/jth.14992. Epub 2020 Aug 27.
9
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.科学与标准化委员会通讯：新型冠状病毒肺炎住院患者静脉血栓栓塞症诊断、预防及治疗的临床指南
J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929.
10
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.